Web Exclusives

College and Cancer: When Big Life Events Collide
Patient StoriesSurvivorshipWeb Exclusives
Samantha Watson was diagnosed with cancer while she was a student at Brandeis University, in Boston.
Elotuzumab, First-in-Class Monoclonal Antibody Immuno­­therapy, Improves Outcomes in Patients with Multiple Myeloma
ImmunotherapyMultiple MyelomaWeb Exclusives
“This therapy is an innovative approach, one that combines the precision of a targeted, immune-based therapy with traditional myeloma therapy. The results are very encouraging, giving renewed hope to patients who have relapsed,” says ASCO President-Elect Julie M. Vose, MD, MBA, Chief of the Division of Oncology/Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha.
Recommendations for the Prevention and Treatment of CIPN
Web Exclusives
The American Society of Clinical Oncology releases recommendations for the prevention and management of chemotherapy-induced peripheral neuropathy (CIPN) in survivors of adult cancers.
How to Prepare for Hair Loss from Cancer Therapy
SurvivorshipWeb Exclusives
Here are some practical tips for dealing with hair loss as a result of cancer therapy.
Financial SupportWeb Exclusives
Learning you have cancer can throw your world into a tailspin. But there are some things you can do to ease the burden of the disease and help you maintain control over your life.
Dietary Supplements: Too Much of a Good Thing?
Nutrition & CancerWeb ExclusivesWellness Corner
More than 60% of all American adults take dietary supplements in an effort to improve their health. However, recent research shows that taking excess amounts of vitamin supplements may increase the risk for cancer in some people.
Does Caffeine Have Hidden Benefits Against Cancer?
Nutrition & CancerWeb ExclusivesWellness Corner
Millions of Americans rely on a morning “cup of Joe” to start their day, but can coffee help fight cancer, too?
New Biomarker May Predict Risk for Uterine Cancer Recurrence
Web ExclusivesCancer Biomarkers
A new study that included 500 women with uterine cancer diagnosed between 1981 and 2007 led to the discovery of a biomarker that may be able to identify those who are at high risk for uterine cancer recurrence.
Page 8 of 9
Results 71 - 80 of 82

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.